African Biosciences Ltd is responding to the Covid-19 pandemic by providing private sector testing through a primarily B2B platform. Before the pandemic very few healthcare facilities including medical testing labs, hospitals and clinics in Nigeria offered any kind of clinical molecular diagnostics due to many infrastructural, technical and logistics challenges. Now there are some laboratories across Nigeria that offer molecular diagnostics testing for Covid-19, but their capacity to serve the market is hampered by lack of skilled technical personnel and reagents, and strictly narrow criteria of who can get tested.African Biosciences Ltd is offering Covid-19 testing specifically for companies and organizations to secure the health of their workers, and for individuals concerned about own exposure. The platform is a seamless workflow and logistics platform to handle sample collection, sample preparation, rapid antibody testing, real time RT-PCR testing and results delivery.Our solution allows companies to sign up with us to provide on-going testing throughout the Covid-19 pandemic and thereafter for wellness testing and healthcare surveillance.

Resilience - we're improving the broader infrastructure for responding to pandemic outbreaks.,Recovery - we're positioned to support in the recovery of those directly affected.,Response - we're responding directly to issues caused or exacerbated by the COVID-19 outbreak.

I have a market ready product/service. I have sold to customers.

African Biosciences Ltd was founded by Dr Ikhide Imumorin, who brings very strong scientific and technical background in bioscience research, harnessed over 24 years in US academic system as a graduate student, postdoctoral researcher and professor. He was on the faculty at Cornell University, Ithaca, NY for 7 years. He holds PhD in Animal Genetics and Genomics from Texas A&M University, College Station.Dr Ore Sofekun is Financial Advisor and Strategy Consultant. Ore brings solid credentials in general management, finance and accounting, business analysis and process improvement, and operational risk assessment to the company. She was a management consultant with Diamond Management and Technology Consultants in Chicago and clients included Goldman Sachs Morgan Stanley, AllState Investments and Kraft Foods. She holds MS and PhD in Chemical Engineering from Iowa State University and MBA from The Wharton School of the University of Pennsylvania. ABL has trained over 400 students and researchers in bioinformatics, genomics, molecular biology and biotechnology since 2016, including recent training of 80 molecular lab technicians in molecular diagnostics. Before Covid-19, there were no molecular diagnostics labs in Nigeria. ABL wants to launch molecular diagnostics services to serve the individual, corporate, clinical, Govt., judicial and law enforcement sectors in Nigeria through a B2B platform. We want to start with molecular testing of Covid-19.

Nigeria, Ghana, Benin Republic

No